Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Eva Martinez-Moragon"'
Autor:
David De la Rosa, Miguel-Angel Martínez-Garcia, Rosa Maria Giron, Montserrat Vendrell, Casilda Olveira, Luis Borderias, Luis Maiz, Antoni Torres, Eva Martinez-Moragon, Olga Rajas, Francisco Casas, Rosa Cordovilla, Javier de Gracia
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177931 (2017)
Few studies have evaluated the coexistence of bronchiectasis (BE) and chronic obstructive pulmonary disease (COPD) in series of patients diagnosed primarily with BE. The aim of this study was to analyse the characteristics of patients with BE associa
Externí odkaz:
https://doaj.org/article/853864b397084dd293940b51de1adc72
Autor:
Eva Martinez-Moragon
Publikováno v:
Archivos de Bronconeumología.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::affae546c3b389b76d622fca09c15e4b
https://doi.org/10.1016/j.arbres.2023.05.007
https://doi.org/10.1016/j.arbres.2023.05.007
Autor:
Alicia Padilla-Galo, Isabel Moya Carmona, Pilar Ausín, Luis Carazo Fernández, Ismael García-Moguel, José Luis Velasco-Garrido, Rubén Andújar-Espinosa, Francisco Casas-Maldonado, Eva Martínez-Moragón, Carlos Martínez Rivera, Elisabet Vera Solsona, Fernando Sánchez-Toril López, Andrea Trisán Alonso, Marina Blanco Aparicio, Marcela Valverde-Monge, Borja Valencia Azcona, Marta Palop Cervera, Javier Nuevo, Jesús Sánchez Tena, Gustavo Resler, Elisa Luzón, Alberto Levy Naon
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background The ORBE II study aimed to describe the characteristics and clinical outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real-world setting in Spain. Methods ORBE II (NCT04648839) was an
Externí odkaz:
https://doaj.org/article/9b86c4ec06e54e6d8ecfa9b7342daea8
Autor:
Cristina De Juana, Susana Herrera, Silvia Ponce, Sergio Calvache, Loubna Dahmazi, Raffaele Vitale, Alberto José Ferrer, Verónica Valentín, Marta Acosta, Irene López, Eva Martínez-Moragón, Respiratory medicine Unit of Universitary Hospital Doctor Peset of Valencia (Spain)
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Few studies have evaluated the long-term impact on health-related quality of life (HRQoL) in patients who have been hospitalized for COVID-19 pneumonia. Specific follow-up should be carried out to detect and treat possible pulmona
Externí odkaz:
https://doaj.org/article/eae1a1f09ac446c3a409c0da914897be
Autor:
Luis Puente-Maestu, Ignacio Dávila, Santiago Quirce, Astrid Crespo-Lessmann, Eva Martínez-Moragón, Javier Sola, María Luisa Nieto, Francisco Javier González-Barcala, Luis Cea-Calvo, Marta Sánchez-Jareño, Cristina Rivas-Pardinas, Christian Domingo
Publikováno v:
ERJ Open Research, Vol 9, Iss 5 (2023)
Background Chronic cough (cough lasting for ≥8 weeks) can lead to significant impairment in quality of life (QoL). Using patient-reported outcomes, this cohort study assessed the perceived impact of chronic cough on QoL and everyday life in patient
Externí odkaz:
https://doaj.org/article/c79d0cd8ffa64a2d98b246cb789094cd
Autor:
Nieves Navarro, Ruben Lera, Eva Martinez Moragon, Alexandra Calle, Ildealfonso Furest, Ignacio Inchaurraga
Publikováno v:
1.4 Interventional Pulmonology.
Aim: To Evaluate the efficacy differences and complications between CT guided transthoracic fine-needle aspiration samples (FNA) and core needle biopsy (CNB). Methods: All patients with suspected lung cancer in whom were realized CT guided transthora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::257f6eb8bd6209be34ce1658db5e6f87
https://doi.org/10.1183/13993003.congress-2016.pa3860
https://doi.org/10.1183/13993003.congress-2016.pa3860
Autor:
Christian Domingo, Ana Sogo, Enrique Casado, Eva Martínez-Moragón, Marina Blanco-Aparicio, Teresa Carrillo, David Bañas-Conejero, María-Guadalupe Sánchez-Herrero
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Oral corticosteroids (OCS) are commonly used for the acute management of severe asthma exacerbations or as maintenance therapy; however, chronic use is associated with significant toxicities, e.g., osteoporosis. In the REal worlD Effectiveness and Sa
Externí odkaz:
https://doaj.org/article/15172a2df12d44d4ab1898c2583ba751
Autor:
Eva Martinez Moragon, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Marta Lleonart Dormuà, Juan Jose Liñana Santafé
Publikováno v:
5.3 Allergy and Immunology.
Introduction: In a Spanish cohort of uncontrolled patients(pts) who initiated omalizumab(OMA) in the clinical practice, symptoms and exacerbations were significantly improved. Here, we describe the concomitant change in asthma-related healthcare reso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d9088b0cb58035ec619070f3c54cbad
https://doi.org/10.1183/13993003.congress-2015.pa2562
https://doi.org/10.1183/13993003.congress-2015.pa2562
Autor:
Eva Martinez Moragon, Ildefonso Furest Carrasco, Sonia Cepeda Madrigal, Arolqui González Castillo, Ignacio Inchaurraga Álvarez
Publikováno v:
4.3 Pulmonary Circulation and Pulmonary Vascular Disease.
Objective: To evaluate the clinical features and mortality in patients diagnosed with PE and cancer. Methods: The clinical and demographic characteristics in all patients diagnosed with pulmonary embolism PE in our hospital from January 1 st 2012 - D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5bd7ac041d1e4da0f561e3e2a453a04
https://doi.org/10.1183/13993003.congress-2015.pa4571
https://doi.org/10.1183/13993003.congress-2015.pa4571
Autor:
Eva Martínez-Moragón, Ismael García-Moguel, Javier Nuevo, Gustavo Resler, ORBE study investigators
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Benralizumab, a monoclonal antibody targeting the human interleukin-5 (IL-5) receptor (IL-5R), was used before marketing authorisation in Spain in a real world setting as part of an early-access programme (EAP) to treat patients w
Externí odkaz:
https://doaj.org/article/a12ef05dc29d475e83545e62a7fcf405